
Satish Rampuria
Examiner (ID: 6815, Phone: (571)272-3732 , Office: P/2193 )
| Most Active Art Unit | 2193 |
| Art Unit(s) | 2191, 2193, 2124 |
| Total Applications | 1171 |
| Issued Applications | 974 |
| Pending Applications | 68 |
| Abandoned Applications | 144 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17200057
[patent_doc_number] => 20210340152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => CRYSTALLINE FORMS OF A TRIAZOLOPYRIMIDINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/371399
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371399
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371399 | Crystalline forms of a triazolopyrimidine compound | Jul 8, 2021 | Issued |
Array
(
[id] => 18628141
[patent_doc_number] => 20230286975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => IMPROVED METHOD FOR THE PRODUCTION OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND NOVEL DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/014858
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014858
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014858 | IMPROVED METHOD FOR THE PRODUCTION OF LYSERGIC ACID DIETHYLAMIDE (LSD) AND NOVEL DERIVATIVES THEREOF | Jul 6, 2021 | Pending |
Array
(
[id] => 18628157
[patent_doc_number] => 20230286998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => SUCCINATE SALTS OF OCTAHYDROTHIENOQUINOLINE COMPOUND AND CRYSTALS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/004353
[patent_app_country] => US
[patent_app_date] => 2021-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004353
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004353 | SUCCINATE SALTS OF OCTAHYDROTHIENOQUINOLINE COMPOUND AND CRYSTALS THEREOF | Jul 4, 2021 | Pending |
Array
(
[id] => 19318269
[patent_doc_number] => 20240239811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T
[patent_app_type] => utility
[patent_app_number] => 18/014057
[patent_app_country] => US
[patent_app_date] => 2021-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 96990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -69
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18014057
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/014057 | 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T | Jul 1, 2021 | Pending |
Array
(
[id] => 18582846
[patent_doc_number] => 20230265101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-24
[patent_title] => Preparation Of A Pyrimidinyl-3,8-Diazabicyclo[3.2.1]Octanylmethanone Derivative And Salt Thereof
[patent_app_type] => utility
[patent_app_number] => 18/004109
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004109
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004109 | Preparation Of A Pyrimidinyl-3,8-Diazabicyclo[3.2.1]Octanylmethanone Derivative And Salt Thereof | Jun 29, 2021 | Pending |
Array
(
[id] => 18160427
[patent_doc_number] => 20230027019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE
[patent_app_type] => utility
[patent_app_number] => 17/361758
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17361758
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/361758 | Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use | Jun 28, 2021 | Issued |
Array
(
[id] => 18093119
[patent_doc_number] => 20220411460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => MODIFIED GLUCOCORTICOIDS
[patent_app_type] => utility
[patent_app_number] => 17/362440
[patent_app_country] => US
[patent_app_date] => 2021-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17362440
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/362440 | Modified glucocorticoids | Jun 28, 2021 | Issued |
Array
(
[id] => 18666225
[patent_doc_number] => 11773102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Heterocyclic compounds as PI3K-g inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/356984
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70555
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356984 | Heterocyclic compounds as PI3K-g inhibitors | Jun 23, 2021 | Issued |
Array
(
[id] => 17546604
[patent_doc_number] => 20220117945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/356421
[patent_app_country] => US
[patent_app_date] => 2021-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356421 | ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF | Jun 22, 2021 | Abandoned |
Array
(
[id] => 18461457
[patent_doc_number] => 11685740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-27
[patent_title] => Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same
[patent_app_type] => utility
[patent_app_number] => 17/349042
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61368
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 398
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349042
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349042 | Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same | Jun 15, 2021 | Issued |
Array
(
[id] => 18529901
[patent_doc_number] => 20230234968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/009481
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18009481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/009481 | METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF | Jun 9, 2021 | Pending |
Array
(
[id] => 18830810
[patent_doc_number] => 20230399335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => PROCESS FOR THE PREPARATION OF ASENAPINE IN THE FORM OF ITS FREE BASE
[patent_app_type] => utility
[patent_app_number] => 18/010922
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18189
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010922
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010922 | PROCESS FOR THE PREPARATION OF ASENAPINE IN THE FORM OF ITS FREE BASE | Jun 3, 2021 | Pending |
Array
(
[id] => 18786038
[patent_doc_number] => 20230373989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => N-PHENYLAMINOCARBONYL PYRIDINO-, PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65
[patent_app_type] => utility
[patent_app_number] => 17/999008
[patent_app_country] => US
[patent_app_date] => 2021-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999008
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999008 | N-PHENYLAMINOCARBONYL PYRIDINO-, PYRIMIDINO AND BENZO-TROPANES AS MODULATORS OF GPR65 | Jun 3, 2021 | Pending |
Array
(
[id] => 17082010
[patent_doc_number] => 20210277016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => DRUG DELIVERY AND IMAGING CHEMICAL CONJUGATE, FORMULATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/330417
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13786
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/330417 | Drug delivery and imaging chemical conjugate, formulations and methods of use thereof | May 25, 2021 | Issued |
Array
(
[id] => 18468777
[patent_doc_number] => 20230203059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => MACROCYCLIC JAK INHIBITOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/000016
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 689
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000016
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/000016 | MACROCYCLIC JAK INHIBITOR AND USES THEREOF | May 20, 2021 | Abandoned |
Array
(
[id] => 17096850
[patent_doc_number] => 20210284641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-16
[patent_title] => AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/324520
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324520 | Azabenzimidazoles and their use as AMPA receptor modulators | May 18, 2021 | Issued |
Array
(
[id] => 17243431
[patent_doc_number] => 20210363174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => CATIONIC STEROIDAL ANTIMICROBIAL COMPOUNDS WITH ENDOGENOUS GROUPS
[patent_app_type] => utility
[patent_app_number] => 17/324329
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 252
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324329 | Cationic steroidal antimicrobial compounds with endogenous groups | May 18, 2021 | Issued |
Array
(
[id] => 17067216
[patent_doc_number] => 20210269431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => SMALL MOLECULE PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) INHIBITORS AND METHODS OF TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/320381
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320381 | SMALL MOLECULE PROTEIN ARGININE METHYLTRANSFERASE 5 (PRMT5) INHIBITORS AND METHODS OF TREATMENT | May 13, 2021 | Abandoned |
Array
(
[id] => 19291566
[patent_doc_number] => 12030912
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Cationic steroidal antimicrobial compounds with urethane linkages
[patent_app_type] => utility
[patent_app_number] => 17/318206
[patent_app_country] => US
[patent_app_date] => 2021-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9710
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17318206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/318206 | Cationic steroidal antimicrobial compounds with urethane linkages | May 11, 2021 | Issued |
Array
(
[id] => 18484901
[patent_doc_number] => 20230212215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => GLUCOCORTICOID RECEPTOR MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/923466
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14606
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 580
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923466
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/923466 | GLUCOCORTICOID RECEPTOR MODULATORS | May 6, 2021 | Pending |